These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31810804)

  • 21. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
    Ho NT; Lansang P; Pope E
    J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic efficacy of intralesional bleomycin injection for laryngopharyngeal haemangioma in adults.
    Liu F; Xiao Y; Wang J
    Acta Otolaryngol; 2019 Dec; 139(12):1117-1121. PubMed ID: 31556768
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma.
    McCuaig CC; Dubois J; Powell J; Belleville C; David M; Rousseau E; Gendron R; Jafarian F; Auger I
    Pediatr Dermatol; 2009; 26(2):203-12. PubMed ID: 19419474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
    Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
    Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to use bleomycin A5 for infantile maxillofacial haemangiomas: clinical evaluation of 82 consecutive cases.
    Luo Q; Zhao F
    J Craniomaxillofac Surg; 2011 Oct; 39(7):482-6. PubMed ID: 20675147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralesional Bleomycin Injection for Propranolol-Resistant Hemangiomas.
    Chang L; Chen H; Yang X; Jin Y; Ma G; Lin X
    J Craniofac Surg; 2018 Mar; 29(2):e128-e130. PubMed ID: 29381619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
    Yilmaz L; Dangoisse C; Semaille P
    Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical propranolol therapy for infantile hemangiomas.
    Kunzi-Rapp K
    Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
    Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
    J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intratumor bleomycin-A5 injection under electrolaryngoscope for treatment of large laryngopharyngeal and laryngeal hemangioma].
    Huang YD; Chen JF; Xia SW; Huang ZX; Wang GY; Luo XH; Luo CJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):492-4. PubMed ID: 16624762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.
    Muir T; Kirsten M; Fourie P; Dippenaar N; Ionescu GO
    Pediatr Surg Int; 2004 Jan; 19(12):766-73. PubMed ID: 14740248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.
    Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X
    Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Infantile hemangioma: a new indication for propranolol? Retrospective study: a case-series of 25 infants].
    Yilmaz L; Dangoisse C; Semaille P
    Rev Med Brux; 2015; 36(1):3-9. PubMed ID: 25856965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical Ultrasound Characteristics of Infantile Hemangiomas That May Potentially Affect Involution.
    McNab M; García C; Tabak D; Aranibar L; Castro A; Wortsman X
    J Ultrasound Med; 2021 Jun; 40(6):1125-1130. PubMed ID: 32896906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symplastic hemangioma developing over an infantile hemangioma during propranolol treatment.
    Downey C; Pino G; Zambrano MJ; Kramer D; Cervilla K; González S
    Pediatr Dermatol; 2019 Nov; 36(6):961-962. PubMed ID: 31468563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective case series of increased oral propranolol dosage for infantile hemangiomas.
    Huang AH; Mannschreck D; Aggarwal P; Mahon M; Cohen BA
    Pediatr Dermatol; 2020 Nov; 37(6):1057-1062. PubMed ID: 32869385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical application of imiquimod for the treatment of infantile hemangiomas].
    Ma G; Lin XX; Jiang CH; Chen H; Li W; Hu XJ; Jin YB; Chen D; Chen XD; Ye XX
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):411-4. PubMed ID: 22292400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional sonography in the diagnosis of hepatic hemangiomas.
    Polaków J; Ładny JR; Janica J; Serwatka W; Walecki J; Puchalski Z
    Rocz Akad Med Bialymst; 2001; 46():182-8. PubMed ID: 11780561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral propranolol for infantile hemangiomas beyond the proliferative phase.
    Kagami S; Katori T
    J Dermatol; 2018 Oct; 45(10):1199-1202. PubMed ID: 30051930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome.
    Kaylani S; Theos AJ; Pressey JG
    Pediatr Dermatol; 2013; 30(6):e194-7. PubMed ID: 23316753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.